Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cidara Therapeutics

44.95
+23.93113.84%
Post-market: 47.832.88+6.41%19:59 EDT
Volume:6.74M
Turnover:276.45M
Market Cap:582.99M
PE:-1.68
High:45.39
Open:40.63
Low:37.76
Close:21.02
Loading ...

BUZZ-Cidara Therapeutics launches $250 mln equity offering after stock soars

Reuters
·
3 hours ago

BRIEF-Cidara Therapeutics To Commence $250 Million Public Offering

Reuters
·
4 hours ago

Cidara Therapeutics Plans $250 Million Shares Offering

MT Newswires Live
·
4 hours ago

Cidara Therapeutics Inc - to Commence $250 Mln Public Offering

THOMSON REUTERS
·
4 hours ago

Cidara Announces Proposed Public Offering of Common Stock

THOMSON REUTERS
·
4 hours ago

Press Release: Cidara Announces Proposed Public Offering of Common Stock

Dow Jones
·
4 hours ago

Top Midday Gainers

MT Newswires Live
·
6 hours ago

Crude Oil Falls 1%; US Services PMI Declines In June

Benzinga
·
8 hours ago

Cidara Therapeutics Is Maintained at Buy by Needham

Dow Jones
·
Yesterday

Needham Adjusts Cidara Therapeutics Price Target to $54 From $36, Maintains Neutral Rating

MT Newswires Live
·
Yesterday

Cidara Therapeutics Inc : Needham Raises Target Price to $54 From $36

THOMSON REUTERS
·
Yesterday

Cidara Therapeutics, Inc. : H.c. Wainwright Raises Target Price to $53 From $41

THOMSON REUTERS
·
Yesterday

Sector Update: Health Care Stocks Flat to Lower Premarket Monday

MT Newswires Live
·
Yesterday

Cidara Says Influenza Prevention Drug Meets Primary, Secondary Endpoints; Shares Jump Pre-Bell

MT Newswires Live
·
Yesterday

Top Premarket Gainers

MT Newswires Live
·
Yesterday

Why Is Cidara Therapeutics Stock (CDTX) Up 80% Today?

TIPRANKS
·
Yesterday

BRIEF-Cidara Therapeutics Announces Positive Topline Results From Its Phase 2B Navigate Trial

Reuters
·
Yesterday

Cidara Therapeutics Inc - Study Meets Primary and Secondary Efficacy Endpoints

THOMSON REUTERS
·
Yesterday

Cidara Therapeutics Announces Positive Topline Results From Its Phase 2B Navigate Trial Evaluating Cd388, a Non-Vaccine Preventative of Seasonal Influenza

THOMSON REUTERS
·
Yesterday

Cidara Therapeutics Inc - Cd388 Well-Tolerated With No Safety Signals Observed

THOMSON REUTERS
·
Yesterday